Irene De Biase

Irene De Biase, MD, PhD

Languages spoken: English, Italian

Academic Information

Departments Primary - Pathology

Academic Office Information

irene.debiase@path.utah.edu

Board Certification

  • American Board of Medical Genetics (Clinical Biochemical Genetics)

Education History

Fellowship Greenwood Genetic Center
 Fellow
University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology
 Postdoctoral Fellow
Doctoral Training Federico II University
 PhD
Federico II University
 MD

Selected Publications

Journal Article

  1. Prinzi J, Pasquali M, Hobert JA, Palmquist R, Wong KN, Francis S, De Biase I (2023). Diagnosing X-Linked Adrenoleukodystrophy after Implementation of Newborn Screening: A Reference Laboratory Perspective. Int J Neonatal Screen, 9(4). (Read full article)
  2. Yuzyuk T, McDonald CM, Zuromski LM, De Biase I, Johnson L, Williams N, Meihls S, Asfour F (2023). Improvement of lipid and lipoprotein profiles in children and adolescents with cystic fibrosis on CFTR modulator therapy. J Cyst Fibros. (Read full article)
  3. De Biase I, Yuzyuk T, Cui W, Zuromski LM, Moser AB, Braverman NE (2023). Quantitative analysis of ethanolamine plasmalogen species in red blood cells using liquid chromatography tandem mass spectrometry for diagnosing peroxisome biogenesis disorders. Clin Chim Acta, 542, 117295. (Read full article)

Abstract

  1. Nelson HA, De Biase I, Balogun K, McDonald CM, Meihls S, Asfour F, Yuzyuk T (2023). CFTR Modulator Therapy Increases Plasma Concentrations of Vitamin A in Patients with Cystic Fibrosis [Abstract]. 69(1, Supplement), A-340.